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modalities have been developed, including ligation proxi-
mal and distal to the aneurysm, coil embolization, and the
insertion of endovascular stented grafts.6-12 Midterm
results of endovascular grafting for isolated IAAs have
been reported. These reports allude to size reduction of
the aneurysms with successful exclusion.10,11 However, no
systematic evaluations of iliac aneurysm diameter changes
with endovascular graft (EVG) repair have been pub-
lished. The current report delineates a 72-month experi-
ence including the evaluation of size changes of IAAs after
exclusion by EVGs.
METHODS
Patients and anatomy. Thirty-one patients (27
men and 4 women) with 35 true IAAs underwent treat-
ment at Montefiore Medical Center between January
1993 and April 1999. Our criteria for repairing IAAs
were asymptomatic aneurysms with more than a 3.5-cm
diameter, aneurysms with a rapid increase in diameter 
(> 0.5 cm/y as demonstrated on computed tomographic
[CT] scans), or any symptomatic aneurysm. One patient
with a 2.5-cm common IAA was treated for rapid
increase in aneurysm size over 6 months (from 2.0-2.5
cm) and progressive distal ischemia thought to be a
result of embolization. Patients with pseudoaneurysms,
Isolated aneurysms of the iliac arteries (IAAs) are rare,
accounting for 2% to 7% of aortoiliac aneurysms.1-7 These
aneurysms can rupture, embolize, thrombose, or exert
pressure on surrounding viscera when these lesions
become symptomatic. Morbidity and mortality rates of
emergency surgery are much higher than for elective
surgery.3 However, elective open surgical repair may also
be technically challenging, especially in the setting of pre-
vious aortic surgery. Therefore, alternative treatment
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Objective: Precise diameter changes in iliac artery aneurysms (IAAs) after endovascular graft (EVG) repair are yet to be deter-
mined. This report describes the midterm size changes in isolated IAAs 13 to 72 months after treatment with an EVG.
Methods: From January 1993 to April 1999, 31 patients with 35 true isolated IAAs (32 common iliac and 3 hypogas-
tric) had these lesions treated with EVGs and coil embolization of the hypogastric artery or its branches. The EVG
used in this study consisted of a balloon-expandable stent attached to a polytetrafluoroethylene graft. Contrast-
enhanced spiral computed tomographic scans were performed at 3- to 6-month intervals to follow the aneurysms for
change in diameter and endoleaks.
Results: Thirty patients had a decrease in the size of their iliac aneurysms with EVG repair. All EVGs remained patent.
All patients, except for one, were followed up for 13 to 72 months (mean, 31 months). The pretreatment aneurysm size
ranged from 2.5 to 11.0 cm in diameter (mean, 4.6 ± 1.62 cm). After EVG treatment, the aneurysms ranged from 2.0
to 8.0 cm in diameter (mean, 3.8 ± 1.36 cm). The change in aneurysm diameter ranged from 0.5 to 3.1 cm (mean, 1.1
± 0.62 cm) with an average change of –0.516 ± 0.01 cm/y for the first year. Five patients died of their intercurrent med-
ical conditions during the follow-up period. One of the patients had a new endoleak and an increase in common iliac
aneurysm size 18 months after EVG treatment, despite an early contrast-enhanced computed tomographic scan that
showed no endoleak. This patient’s aneurysm ruptured, and a standard open surgical repair was successfully performed.
Another patient had a decrease in hypogastric aneurysm size after EVG treatment and no radiographic evidence of an
endoleak, but eventually the aneurysm ruptured. He was successfully treated with a standard open surgical repair.
Conclusions: EVGs can be an effective treatment for isolated IAAs. Properly treated with EVGs, IAAs decrease in size.
The enlargement of an IAA, even if no endoleak can be detected, appears to be an ominous sign suggestive of an
impending rupture. IAAs that enlarge should be closely evaluated for an endoleak. If an endoleak is detected, it should
be eliminated if possible. If an endoleak cannot be found, open surgical repair should be considered. (J Vasc Surg
2001;33:289-95.)
aortoiliac aneurysms, or anastomotic aneurysms from
previous aortic surgery were excluded. The mean age of
the patients was 69 years (range, 63-91). Thirty-five
fusiform aneurysms were treated, including 32 common
iliac and three internal iliac. Twenty-three aneurysms
were on the right side, and 12 were on the left side. The
aneurysms ranged in maximal diameter from 2.5 to 11
cm (mean, 4.6 ± 1.62 cm [SEM 0.28]). Only three
patients had complaints of abdominal, pelvic, or rectal
pain. None of the remaining patients had symptoms,
and their aneurysms were detected incidentally. Pulsatile
masses were found during the rectal examination of two
patients with hypogastic artery aneurysms. Three
patients had palpable pulsatile abdominal masses. The
remaining 26 patients had no remarkable findings on
their physical examination.
All the patients had at least one significant comorbid
medical condition, which increased the risk for standard
surgical repair as suggested by the Society for Vascular
Surgery/International Society for Cardiovascular Surgery
Ad Hoc Committee on Reporting Standards.13 These
comorbid conditions included coronary artery disease
with previous myocardial infarction in 20 patients (65%),
hypertension in 13 (42%), chronic obstructive pulmonary
disease in 7 (23%), chronic renal insufficiency in 4 (13%),
and major intra-abdominal or retroperitoneal procedures
in 8 (26%).
Preoperative evaluation. All patients underwent a
preoperative contrast-enhanced CT scan, and standard
measurements were taken. On the basis of this informa-
tion, one of six previously described methods of EVG
repair was used (Fig 1).12
EVG device. All aneurysms were excluded with a
transluminally placed EVG constructed as described in our
previous reports.10,12 The EVG consisted of a polytetra-
fluoroethylene graft (W. L. Gore and Associates, Flagstaff,
Ariz, and Impra, Inc, Tempe, Ariz) sutured to a Palmaz
balloon-expandable stent (P308 or P4014; Johnson &
Johnson Interventional Systems, Warren, NJ), with 50%
to 75% of the stent covered by the overlying graft. The
ends of the graft material were marked with 0.010 in
radiopaque gold wire for precise proximal deployment and
placement of a second distal stent across the end of the
graft when necessary. The EVG was coaxially mounted on
an appropriately sized angioplasty balloon and packaged
within a 14F to 20F introducer sheath.
Informed consent was obtained by the patients before
all procedures. All EVGs were used under an investigator-
sponsored Food and Drug Administration investigational
device exemption with the approval of the institutional
review board.
EVG deployment. All EVGs were placed in the oper-
ating room under fluoroscopic guidance as described pre-
viously.10-12 The EVGs were introduced into the femoral
artery through an open femoral arteriotomy and advanced
to the planned site of deployment. The introducer sheath
was retracted, and the balloon catheter was inflated to
deploy the proximal stent. Early in our experience, we
attempted to fix the distal end of the graft within the
external iliac artery by placing a second stent across it (12
patients). However, we found that placing the second
stent occasionally resulted in displacement of the graft
from the planned distal fixation site, necessitating place-
ment of an additional graft. Subsequently, we developed a
technique in which the distal end of the graft was made
long enough to emerge from the arteriotomy in the com-
mon femoral artery.14 The graft was then cut to the
appropriate length and sutured within the vessel, thereby
creating an endovascular anastomosis. This technique was
used in 19 patients.
Hypogastric artery aneurysms were treated with coil
embolization of the nonaneurysmal anterior and posterior
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Fig 1. Techniques used for EVG repair of isolated IAAs. A,
Common iliac artery (CIA) with adequate proximal and distal
neck for fixation; EVG placed completely within CIA (n = 8). B,
CIA with adequate proximal neck only; EVG placed in proximal
CIA and extended to external iliac artery (EIA) with coil
embolization of internal iliac artery (IIA) (n = 2). C, CIA with
adequate proximal neck only; EVG placed in proximal CIA and
extended to common femoral artery for sutured anastomosis (n =
18). D, IIA with normal CIA; EVG in proximal CIA to EIA and
coil embolization of branches (n = 1). E, CIA with inadequate
proximal neck; EVG placed in aorta with coil embolization of IIA
branches, contralateral occluding covered stent and femoro-
femoral bypass graft (n = 1). F, Bilateral CIA and IIA; EVG placed
in aorta and distal stent in EIA, coil embolization of IIA branches,
contralateral occluding covered stent, and femorofemoral bypass
graft (n = 1). x, Occlusion coil; o, occluding covered stent.
divisions of the vessel to prevent backfilling of the
aneurysm. The embolizations were performed at the time
of preoperative diagnostic arteriography or in the operat-
ing room just before EVG placement. Completion arteri-
ography with delayed views was performed in every case to
evaluate graft patency and exclusion of the aneurysm.
Postoperative patient follow-up. All patients under-
went serial contrast-enhanced CT scans at 1 month and
subsequently at 3- to 6-month intervals to assess patency,
endoleaks, and change in aneurysm diameter.15 Studies
were performed more frequently if there was suspicion of
an endoleak, an enlargement of the aneurysm, or symp-
toms referable to the aneurysm. Thirty of the 31 patients
underwent 124 postprocedure contrast-enhanced CT
scans (mean, 4 CT scans per patient). One patient was lost
to follow-up for 18 months. Each scan, which included
delayed views, was retrospectively reviewed by the same
investigator either on a high resolution High Speed
Advantage scanner workstation (General Electric Medical
Systems, Milwaukee, Wis) (n = 102) or on a printed hard
copy of the scan (n = 22). Each aneurysm was measured at
its maximal diameter by use of the electronic calipers on the
workstation or by direct measure with calipers and the CT
scan scale printed on each image. Adjustments for tortuos-
ity were made by selecting the smallest cross-sectional
diameter within the largest part of the aneurysm sac. Each
measurement was made in triplicate from the images
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depicting maximal aneurysm diameter. The mean value of
these three measurements was recorded as a data point
reflecting aneurysm diameter. These data were used to cal-
culate changes in aneurysm diameter. Additional informa-
tion regarding the patients’ long-term medical problems,
previous and adjunctive surgical procedures, and death was
obtained by extensive chart review; telephone interviews
with the patients, their primary physicians, or both; and
review of surgery or autopsy findings where applicable.
RESULTS
EVGs were successfully placed in all 31 patients. Four
patients were given general anesthesia, 22 had an epidural
block, and five were given a local anesthetic. The median
operating time was 4.2 hours, ranging from 2.5 to 10
hours. Fluoroscopy time was an average of 41 minutes
(range, 24-95 minutes). Follow-up ranged from 13 to 72
months with a mean of 31 months. All EVGs remained
patent throughout the follow-up period. All aneurysms
(both common iliac and hypogastric) had a decrease in
diameter, with one notable exception described later.
Perioperative major complications included one episode of
colonic ischemia that spontaneously resolved with antibi-
otic therapy and bowel rest and one episode of distal
embolization that required a distal bypass graft 2 months
postoperatively. There were three episodes of EVG kink-
ing or compression that required additional stent place-
Fig 2. Mean change in IAA diameter over 12 months for small (2.5-4.0 cm), medium (4.1-5.0 cm), and large (> 5.0 cm) aneurysms.
ment within the graft. There was a groin hematoma that
required no further treatment.
Preoperative aneurysm diameters ranged from 2.5 to
11.0 cm (mean, 4.6 ± 1.62 cm). Postoperative aneurysm
diameters ranged from 2.0 to 8 cm (mean, 3.8 ± 1.62 cm)
13 to 72 months after EVG treatment. The greatest
observed change in aneurysm diameter occurred during
the first 12 months after EVG treatment (Fig 2). Mean
regression lines reflecting the average change in aneurysm
diameter for both the 0- to 12-month and 13- to 72-
month periods were calculated. The average rate of change
over the first 12 months was –0.516 ± 0.1 cm/y. The rate
of change after 12 months was –0.12 ± 0.05 cm/y.
Excluded aneurysms (n = 34) decreased in absolute size an
average of 1.1 ± 0.4 cm (range, 0.5-3.1 cm) (Fig 3).
All of the treated IAAs were grouped according to
their maximal diameter into one of three groups: small
(2.5-4.0 cm), medium (4.1-5.0 cm), and large (> 5.0 cm).
All of the small and medium aneurysms decreased in size
after repair (Tables I and II). Seven of the eight aneurysms
in the large group decreased in diameter after EVG exclu-
sion (Table III). One of the large aneurysms increased in
diameter and presented ruptured after being lost to 
follow-up for 18 months. One large hypogastric aneurysm
decreased in diameter during 24 months of follow-up but
subsequently ruptured. Both of these cases (7%) required
open surgical repair; both patients survived.
Five patients died because of their intercurrent med-
ical conditions during the follow-up period: three patients
had severe cardiac disease, and two had advanced colon
cancer. Four of these five patients underwent treatment
because of a rapid increase in size of their aneurysms over
a 6-month period. One patient had worsening pelvic pain
that was attributed to the aneurysm. In these five cases,
the opinion of all physicians involved was that the poten-
tial benefits of EVG repair outweighed the risks imposed
by comorbid conditions.
DISCUSSION
Open surgical repair of IAAs can be difficult and tech-
nically challenging, especially in obese patients or in
patients who have previously undergone surgery. This has
prompted the development of endovascular treatment
options.8-12 EVGs have been used for the treatment of
iliac aneurysms with encouraging success. Early and
midterm reports from several centers have demonstrated
high technical success rates with limited morbidity.10-12
Our own anecdotal data as well as those of others also sug-
gest that successfully excluded iliac aneurysms may
decrease in size. The current report was undertaken to
delineate more precisely the diameter changes in isolated
IAAs 13 to 72 months after EVG repair.
Review of the two patients with large IAAs that rup-
tured after endografting may elucidate some of the com-
plexities of EVG repair and underscore the importance of
close follow-up. The first patient was temporarily lost to
follow-up after a postoperative contrast-enhanced CT scan
had revealed complete IAA exclusion. He presented 18
months later with a contained rupture. Preoperative con-
trast-enhanced CT scan at that time demonstrated an
increase in aneurysm diameter and a type I proximal
endoleak due to distal migration of the graft from the
aneurysm neck. We think that this migration was due to
placement of the proximal stent in a pseudoneck contain-
ing circumferential thrombus. Therefore, we currently
favor the use of bifurcated aortic grafts or aortounifemoral
grafts to repair isolated IAAs that do not have well-devel-
oped necks (> 1.5 cm in length) without mural thrombus.
The second patient had been simultaneously treated
for two aneurysms, one common iliac and one hypogas-
tric. On follow-up contrast-enhanced CT scans, no con-
trast was seen within either aneurysm. Although both the
common iliac and hypogastric aneurysms decreased in
diameter, only the hypogastric aneurysm ultimately rup-
tured. It is unclear whether the hypogastric aneurysm had
undergone any undetected enlargement before rupture
because a CT scan was not obtained before emergency
surgical repair. This patient had undergone coil emboliza-
tion of the distal hypogastric artery before undergoing
EVG treatment, and the coils were placed in a thrombus-
lined distal pseudoneck rather than in the hypogastric
branches as intended. We presume that the rupture of the
hypogastric aneurysm occurred as a result of pressure
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Fig 3. A, Preoperative CT scan of common iliac artery aneurysm
and B, 1-year follow-up CT scan. Diameter of the aneurysm
decreased from 4.5 to 3.5 cm.
A
B
transmission through the clot from these hypogastric
branches. We have observed such pressure transmission
through a clot in an experimental model.16 The patency of
these branches was confirmed at surgical exploration at
which time these orifices were oversewn. Ensuring the
placement of coils directly within the normal nonaneurys-
mal branches is therefore essential.
On the basis of our observations, it appears that prop-
erly treated and successfully excluded true IAAs should
decrease in size within 1 year regardless of their initial
diameter. Iliac aneurysms that increase in diameter after
EVG repair are a cause for concern and may rupture. These
IAAs should be thoroughly evaluated for the presence of an
endoleak, which if detected, should be eliminated. If an
enlarging IAA has an endoleak that cannot be eliminated,
open surgical repair should be strongly considered.
Because none of the IAAs remained the same size after
EVG treatment, we conclude that such stability of size is a
rare occurrence. Similarly, because no IAAs remained
unchanged, we cannot offer definitive advice on manage-
ment in such circumstances. However, such stability in
size has been noted after EVG repair of abdominal aortic
aneurysms (AAAs), and many of these AAAs have
remained free of rupture.17 On the other hand, many
effectively excluded AAAs have been observed to shrink in
size18 as was the case with all of our IAAs that were effec-
tively excluded.
The relationship between aneurysm size change and
the presence of an endoleak remains somewhat unclear. At
least two groups of investigators have associated persistent
type I endoleaks with growth of the aneurysm at a rate
equal to that of an untreated aneurysm and risk of rup-
ture.17,18 However, there are other patients who have
endoleaks, especially branch endoleaks (type II), that are
associated with AAA shrinkage.19 In addition, there have
been other patients whose treated AAAs enlarge despite
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the absence of a demonstrable endoleak.19 Whether these
patients have such little flow into their aneurysm sac that
the leak cannot be detected or have transmission of pres-
sure from patent branches through clot to the aneurysm
sac is unknown. Certainly, the latter phenomenon, which
has been termed endotension,20 may be the mechanism
responsible for the ruptured hypogastric aneurysm that
occurred in our second patient.
On the basis of our experience, we conclude that
EVGs are an effective treatment for isolated IAAs. Those
aneurysms that are successfully excluded with an EVG can
be expected to decrease in size. Enlargement of IAAs after
EVG treatment is an ominous sign that may portend rup-
ture. Such enlargement mandates further investigation
and corrective treatment, if possible.
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DISCUSSION
Dr Roger T. Gregory (Norfolk, Va). Thank you, Dr Hobson,
for allowing me to comment on this exciting presentation.
Although our group in Norfolk has had a long-term interest in
endovascular surgery, our aneurysm experience has been confined
to approximately 75 EVT endografts placed during their Phase II
and III trials, followed by the use of the endograft thereafter
when allowed by strict protocol criteria. Thus, our personal expe-
rience with endograft repair of isolated iliac artery aneurysms is
zero. However, that being clarified, our interest as endovascular
surgeons is still high.
The sine qua non of endovascular management of arterial
aneurysms is protection from expansion and rupture. The
Montefiore group reports a large number of iliac artery
aneurysms over a 6-year period, a much larger number than I
have seen in 26 years of practice. There are two large series of iliac
artery aneurysms reported and published in 1999, one from
Mount Sinai and the other from Montefiore. I wonder if these are
the same patients?
I am impressed that all grafts remained patent and that 29 of
the 31 patients had a decrease in aneurysm size. In the one
patient who had an increase in aneurysm size without endoleak by
CAT scan, was color duplex ultrasound used to follow these
grafts? We have found color duplex ultrasound to be perhaps
more accurate in finding endoleaks than CAT scan. I suspect
endoleak was present, since endotension could be the only other
explanation, and I do not believe in endotension. I would have
the same concerns about the hypogastric aneurysm that ruptured.
Although without an increase in aneurysm size, the rupture
occurred without standard warning signs. I am impressed that
you conclude that no change in aneurysm size appears to be an
ominous sign. We have not found this to be the case with
endovascular grafts used for abdominal aortic aneurysms.
I have three questions. First, why not use color duplex ultra-
sound to follow these cases as well as CAT scan? Second, how
long would you follow a patient treated with an endovascular
graft whose isolated iliac artery aneurysm does not decrease in
size? And finally, we have found that small abdominal aortic
aneurysms treated with endovascular grafts have less endoleak
than large aneurysms. Do you think this is true with isolated iliac
artery aneurysms? 
Congratulations on a very stimulating presentation.
Dr Avisesh Sahgal. Thank you, Dr Gregory, for those com-
ments. I’ll try to address your questions as specifically as I can.
First, in your remarks you commented about the series of
iliac aneurysm patients treated with endovascular grafts who came
from our group and Mount Sinai. There was some overlap in
these two reports, but not much. However, neither of these two
studies directly addressed the issue of aneurysm size changes after
endograft treatment. That is why this project was undertaken.
Secondly, your comments about color duplex I think are per-
tinent. Although we agree with your assessment of the use of
color duplex in studying endoleaks and patency in these patients,
we opted not to use that modality. Therefore, CAT scan was our
primary mode of follow-up and size measurement.
Lastly, your question about how long to follow patients that
don’t have any changes in the aneurysm. We had no patients that
didn’t have a change in their aneurysm size. Our patients either
had an increase in aneurysm size or a decrease. Two ruptured,
and both had improper endovascular treatment as detailed in the
manuscript. The remainder of them did not rupture, and they all
had decreased in size. So in patients that have no change, we can-
not offer any proven correct answer as to how to manage them.
Obviously, these patients need to be watched very closely.
Dr Thomas S. Riles (New York, NY). There are two things.
One is we’ve had experience embolizing and thrombosing smaller
iliac aneurysms, and I wanted to know if it was always necessary
to use endografts or if you could have simply thrombosed the
smaller ones?
The second question is, we’ve also had trouble thrombosing
large iliac aneurysms. One patient developed DVT because of the
inflammation surrounding the thrombosed aneurysm and this set
up a pulmonary embolus that was almost lethal, but the patient
survived that. So I wanted to know if you’d had that experience,
the problem with venous thrombosis following thrombosis of
these iliac aneurysms.
Dr Sahgal. In our group of patients, we did not notice a par-
ticular problem with DVT in the follow-up after thrombosis. We
never treated iliac aneurysms by embolization, although we have
experimental data with canine aortic aneurysms and these data
suggest embolization would not be effective. 
Dr William C. Krupski (Denver, Colo). I enjoyed your pre-
sentation very much. As you may know, we’ve had an interest in
iliac aneurysms at the University of Colorado and several years
ago reported a series in which we had a 5% morbidity, no ruptures
after surgical repair, and no operative mortality. I didn’t note in
your presentation that you mentioned any morbidity in your
series. I’d like to know about that. And I’d also like to point out
that you had a 7% rupture rate in which you repaired some
aneurysms as small as 2.5 cm. Isn’t the natural history of small
iliac artery aneurysms relatively benign?
Dr Sahgal. Actually, I’m going to address your second ques-
tion first regarding the natural history. I can recall papers written
by yourself as well as another group from the Cleveland Clinic
where they cite that aneurysms less than 4 cm in size have less
likelihood of rupture than those that are greater than 4 cm in size.
That brings up an interesting point: do we need to fix these
smaller aneurysms, or should we just simply watch them? We can-
not answer that question. However, our patients were selected for
endovascular grafting because they had large or symptomatic iliac
aneurysms and usually a major contraindication to standard sur-
gical repair.
With regard to your other question regarding morbidity and
the mortality following endovascular grafting, there were no peri-
operative deaths, but there were some relatively minor complica-
tions that are detailed in the manuscript or our previous reports.
Dr John W. Hallett, Jr (Rochester, Minn). Those of us who
think that this endovascular technique is a good option for some
iliac artery aneurysms are concerned about the two ruptures you
report. And my question is very specific. Let’s not think too much
about the iliac aneurysms under 5 cm because they rarely rupture.
But let’s take the larger aneurysms. What are you going to tell your
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patients now about the rupture risk after a stent graft? What is the
rupture risk for a large iliac aneurysm (over 6 cm) where you use
this endovascular technique? Surgical repair is safe, as Dr Krupski
emphasizes. Are we frankly telling the patient that some aneurysms
treated by endovascular stents may still eventually rupture?
Dr Frank J. Veith. I would like to make a comment, because I
think some of the discussants missed the point. In the two patients
who ruptured, we made errors that we would not make today. The
first one had a graft placed in what we considered a pseudoneck,
which was thrombus lined. That graft slipped out, became dis-
placed, the patient had a type 1 endoleak, the aneurysm enlarged
and ruptured. In the second patient we made the mistake of plac-
ing the coils, not in the normal-sized branches of the hypogastric
artery, but in a pseudoneck that we thought was a distal normal-
sized distal neck of the hypogastric artery. However, it was not nor-
mal because it was filled with thrombus. That patient never had an
endoleak we could demonstrate, but we believe there was endoten-
sion, Dr Gregory, whereby pressure was transmitted through the
hypogastric branches and caused the aneurysm to rupture.
The other point that we did not stress enough in our presenta-
tion: these were all patients with major contraindications to open
surgery. So I do not think our patients were comparable to Dr
Krupski’s group of patients. Thus, we still feel very enthusiastic,
not about endovascular abdominal aneurysm repair in good-risk
patients, but about endovascular iliac aneurysm repair, particu-
larly in high-risk patients. This is based both on the patency
results and the low rupture rate when these lesions are properly
treated.
Dr Hobson. Thank you for clarifying the presentation from
your institution, Dr Veith, and for correcting Dr Gregory’s
impression on endotension. Thank you very much, Dr Sahgal.
